Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,173 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07359846RecruitingPhase 3
Add-on treatment for severe uncontrolled asthma
This study tests a new add-on medicine called GB-0895 for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this medicine can reduce asthma attacks and improve breathing.
Bakersfield, CaliforniaAges 12–80 - NCT07520461Recruiting
Diet Changes for Ulcerative Colitis Based on Gut Bacteria
This study tests whether a special diet designed to improve your gut bacteria can help control mild ulcerative colitis. You'll receive prepared meals and follow the diet for several weeks to see if it reduces inflammation in your colon.
Minneapolis, MinnesotaAges 18 years+ - NCT07504588RecruitingPhase 2
Comparing two drug combinations for recurrent ovarian cancer after PARP inhibitor treatment
This trial tests whether a new drug combination (sacituzumab govitecan plus bevacizumab) works better than the usual chemotherapy for ovarian cancer that has come back after platinum treatment and PARP inhibitor maintenance. It may offer a new option for people with certain genetic markers (BRCA mutations or HRD).
Fayetteville, ArkansasAges 18 years+ - NCT06487481RecruitingPhase 1
Radiation before surgery for recurrent adrenal cancer
This trial tests whether giving radiation before surgery helps people with adrenal cancer that has come back after previous treatment. It aims to see if this approach can improve outcomes for patients who can have surgery at the NIH.
Bethesda, MarylandAges 18–120 - NCT07541079RecruitingPhase 3
Testing a New Breast Cancer Drug for Women Who Can't Tolerate Current Therapy
This study tests giredestrant, a new hormone-blocking medication, in postmenopausal women with early-stage ER+ breast cancer who have experienced intolerable side effects from their current aromatase inhibitor therapy. The trial will measure how well you tolerate this new drug and how it affects your quality of life.
Fountain Valley, CaliforniaAges 18 years+ - NCT05564390RecruitingPhase 2
MyeloMATCH screening to match you to AML or MDS treatment
This study screens people with newly suspected acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) to see which treatment approach fits best—either a specific study treatment or standard care. It may help by directing you to the right option and by sharing your blood/bone marrow samples for research.
Birmingham, AlabamaAges 18 years+ - NCT07775313Enrolling by invitationPhase 1/Phase 2
Gene therapy for WHIM syndrome
This trial tests a one-time gene therapy treatment for WHIM syndrome, a rare immune disorder. It aims to fix the genetic cause to improve your body's ability to fight infections. Your stem cells will be collected, edited in a lab, and given back to you after some chemotherapy to prepare your body.
Bethesda, MarylandAges 3–75 - NCT06862388RecruitingPhase 1/Phase 2
Stem cell treatment for recent brain bleeding
This study tests whether giving stem cells shortly after a brain bleed can help recovery. It aims to see if the treatment is safe and may improve healing and function.
Wuhan, HubeiAges 18–65 - NCT07697456RecruitingPhase 2
Study of advanced therapies for Crohn's or ulcerative colitis
This study tests advanced treatments for people with moderate to severe Crohn's disease or ulcerative colitis who haven't responded to at least one previous therapy. It aims to find better options for managing these conditions.
Dothan, AlabamaAges 18–75 - NCT07570979RecruitingPhase 1
Testing INR731 for Metastatic Prostate Cancer
This trial tests a new drug called INR731, given by mouth, for men with prostate cancer that has spread to other parts of the body. The study will check if the drug is safe and how well it works, either alone or combined with other prostate cancer medicines.
Boston, MassachusettsAges 18 years+ - NCT01524276Recruiting
Registry to track outcomes of Medtronic medical devices
This is a follow-up registry that collects information from people who have (or will receive) an eligible Medtronic device. It helps the company and doctors better understand how the device works in real-world use.
Birmingham, AlabamaAges Any age - NCT06311214RecruitingPhase 2
Personalized ADC therapy for advanced solid tumors
This trial tests personalized antibody-drug conjugates (ADCs) for advanced solid tumors. It looks for specific proteins on your tumor cells to match you with a treatment that targets them directly.
Duarte, CaliforniaAges 18 years+ - NCT07403721RecruitingPhase 1
Study of AMG 436 for MSI-H/dMMR Cancers
This study tests an experimental drug called AMG 436, alone or with other treatments, for people with advanced solid tumors that have a specific genetic change (MSI-H or dMMR). The goal is to see if the drug can shrink tumors and if it is safe.
Irvine, CaliforniaAges 18–99 - NCT06498349Recruiting
DBS for Parkinson's impulse control problems
This trial tests whether deep brain stimulation (DBS) of the subthalamic nucleus can help control impulse control problems (like gambling, overeating, or shopping) in people with Parkinson's disease. It is for patients whose medication-related impulse symptoms are moderate to severe and who are good candidates for DBS surgery.
CologneAges 18–70 - NCT07225855Recruiting
Support for older adults with head and neck cancer and their caregivers
This trial tests whether a special geriatric assessment (a check-up for older adults) and extra support can help people aged 60+ with head and neck cancer feel better during chemotherapy and radiation. It also looks at how this helps their family or friend caregivers.
Duarte, CaliforniaAges 18 years+ - NCT07526896Recruiting
Testing a new heart pacing method for people with heart failure
This study tests a new way to place a heart device lead to help the heart beat in sync for people with heart failure and a specific abnormal heart rhythm. The goal is to see if this method improves outcomes compared with standard treatment.
Minneapolis, MinnesotaAges 18 years+ - NCT05934331RecruitingPhase 2
Combination therapy for advanced gastrointestinal tumors
This trial tests a new drug called LM-302 combined with other cancer treatments for people with advanced stomach, esophageal, or other gastrointestinal cancers that have stopped responding to standard first-line treatment. The goal is to see if the combination is safe and effective.
ShanghaiAges 18–80 - NCT07214987RecruitingPhase 2
Light therapy before chemotherapy for head and neck cancer
This trial tests whether giving a light-activated treatment (photodynamic therapy) before standard chemotherapy can shrink tumors in people with newly diagnosed head and neck cancer. The goal is to make the cancer easier to treat and improve outcomes.
Boston, MassachusettsAges 18 years+ - NCT07521046RecruitingPhase 1
Adding ropeginterferon to ruxolitinib for myelofibrosis
This trial tests whether adding a drug called ropeginterferon alfa-2b to the standard treatment ruxolitinib can help people with myelofibrosis. Myelofibrosis is a bone marrow disorder, and this combination may reduce symptoms and improve outcomes.
Salt Lake City, UtahAges 18 years+ - NCT06085716RecruitingPhase 2/Phase 3
Combination therapy for cancer-related fatigue
This study tests a combination of treatments to help reduce fatigue in people with advanced cancer. If you have been feeling very tired for at least two weeks, this trial might offer new ways to improve your energy.
Houston, TexasAges 18 years+ - NCT07344779Recruiting
Darolutamide with hormone therapy for advanced prostate cancer
This study looks at how well the drug darolutamide works when combined with hormone therapy, with or without chemotherapy, for men whose prostate cancer has spread. It aims to see how effective this treatment is in everyday medical practice, not just in a research lab.
Many LocationsAges 18 years+ - NCT07881198Recruiting
Cold spray vs laser for warts on hands and feet
This trial compares two treatments for warts on the palms of the hands and soles of the feet: liquid nitrogen (freezing) and a CO₂ laser. The goal is to find out which method works better and has fewer side effects.
Multan, Punjab ProvinceAges 18–50 - NCT05587894RecruitingPhase 2
Testing optimized COVID antiviral treatment in immunocompromised adults
This study tests the best combination and timing of antiviral medicines for people with COVID-19 who have weakened immune systems. It aims to improve outcomes in people with mild to moderate illness.
Bordeaux, BordeauxAges 16 years+ - NCT07607587RecruitingPhase 1
Testing a new weight-loss drug for people who couldn't tolerate GLP-1 shots
This study tests a new injectable medication called cagrilintide for people with obesity who had to stop GLP-1 drugs (like Ozempic or Wegovy) because of stomach problems. The goal is to see if cagrilintide causes fewer stomach side effects while still helping with weight.
Walnut Creek, CaliforniaAges 18 years+
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,173 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.